The transfer of the system shown here to an in vitro preliminary study on the treatment of cancer cells with a ca-Caspase 3 showed for the fusion system a comparative efficiency with increased selectivity compared to the previous data and thus potentially therapeutic use for targeted apoptosis induction in cancer cells with significantly reduced effects on healthy cells of treated tissues. Here, CASP3 is linked to cancer.